Skip to content
Monday, November 16, 2026
Modern Fortune Base

Zimbabwe Declines ‘One-Sided’ US Healthcare Assistance Deal Due to Information Apprehensions

Health funding image
The proposed US funding would have supported programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has declined a substantial US healthcare agreement valued at $367m (272 million pounds) over five years over Washington's demand for sensitive biological samples.

This move became public following a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".

An official spokesman has since explained that the US was seeking biological samples for scientific study and profit but refused to guarantee the resulting advantages from future vaccines.

"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has called for more dialogue to secure a agreement suitable to both sides so the country's critical HIV programme can continue.

Wider Implications

Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a high court halted a related health funding agreement after concerns were filed about the security of citizens' health data.

Since resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.

The agency had overseen aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking direct bilateral agreements to boost transparency and responsibility.

Based on statements, 16 African countries have so far signed these new health pacts, representing more than $18.3bn in committed funds.

Specifics of the Declined Deal

This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this collaboration might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy through US-supported programmes," Tremont commented.

However, official spokesman Nick Mangwana argued the proposed deal was "unequal".

"Our nation was requested to share its genetic material and health information for a long time, with no equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that might result from that shared data," he stated.

"In essence, our nation would supply the raw materials for medical research with no certainty that the end products would be available to our citizens if a new disease outbreak emerge."

National Interest and International Frameworks

He also pointed out that the American exit from the global health body and its pursuit of one-on-one health agreements were disrupting frameworks already established through the global health agency.

Mangwana cited its Pandemic Benefit-Sharing system designed to deal with potential pandemics.

"This system is intended to guarantee that when a nation contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."

The government's concerns regarding the US deal "must not be interpreted as opposition to America," he added.

"We welcome further discussions with our US partners on how future co-operation could be arranged in a way that honours the independence and dignity of each country."

Medical Community Response

Medical experts stated it acknowledged the official position, but suggested that negotiations must proceed given that a large portion of the country's Aids initiatives were funded by external financing.

"If specific concerns arise, including those involving data governance or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," the group added.

The halted deal highlights the ongoing challenges between accepting crucial international aid and protecting a country's data in an ever more data-driven world.

DH
About the author

Deanna Hendricks

Elena Voss is a seasoned financial analyst and writer, dedicated to demystifying personal finance and empowering individuals to build lasting wealth.

Modern Fortune Base

Type to search articles.